University College London Hospital (UCLH) and the Alan Turing Institute are working together on Artificial Intelligence to carry out works which are traditionally done by the doctors and nurses; from deciding which accidental and emergency patients to be consulted first to diagnosing cancer on CT scan.
Positive news that holds hope for the medical fraternity and patients is the urging by UK Prime Minister, Theresa May, for the adoption of artificial intelligence by the NHS and technology companies to diagnose critical diseases such as cancer.
Mountain View, California startup - Qventus a healthcare management tech platform which uses artificial intelligence to improve hospital workflow, closed at $30 million in series B funding which will be used to expand its platform. The funding was led by Bessemer Venture Partners along with few other participants. Including this latest funding, Qventus bagged total $43 million.
Today, Digital behavioral health company, Lyra Health announced that it has raised $45 million in Series B funding in a new financing round including Tenaya Capital, Glynn Capital, Crown Ventures, and Casdin Capital, as well as returning funders Greylock Partners, Venrock, and Providence Ventures.
Suki, a startup that makes an AI-powered and voice-enabled digital assistant for doctors, has just landed $20 million in a funding round led by Venrock, with participation from First Round, Social Capital, and Marc Benioff.
The name Nvidia usually creates a synapse to the video game industry — or more recently the self-driving car business. But now the computer hardware company is looking to get a foothold in the healthcare industry.
A recent report from Accenture analyzed the “near-term value” of AI applications in health care to determine how the potential impact of the technology stacks up against the upfront costs of implementation. Results from the report estimated that AI applications in health care could save up to $150 billion annually for the U.S. health care economy by 2026.
BenevolentAI today announced that it has raised $115 million from new and existing investors at a pre-money valuation of $2 billion in one of the largest funding rounds in the AI pharmaceutical sector.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.